Trial Search Results

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: The Leukemia and Lymphoma Society


Inclusion Criteria:

   - Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification,
   any stage, any grade.

   - Adult or pediatric patients receiving lymph node excision for purposes other than
   cancer therapy (i.e. tonsillectomy, sleep apnea).

   - A routine procedure for tissue collection is planned.

   - Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

   - Patients without NHL or Hodgkin's disease

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study